The evolution of risk-based safety: from TSA PreCheck to COVID-19 will be hosted by hc1 and Daon on January 19, 2021, 1 p.m. – 2:30 p.m. EST

By cyoder® announced today that existing investor Health Cloud Capital has exercised its option to provide additional growth funding, bringing the company’s total Series B capital raise to $10 million. Elevate Ventures also participated in the round. The additional capital will fund continued expansion of several precision health initiatives underway at hc1, including solutions that combat the opioid crisis and optimize prescribing of other prescription drugs.

Subscribe to the blog
Previous Post How Healthcare CRM can Drive Profitability and Efficiencies in Toxicology Labs
Next Post Dives Deeper into Opioid Data, Precision Care